InNexus Biotechnology (InNexus Biotechnology) Total Stockholders Equity : $-6.58 Mil (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Total Stockholders Equity?

InNexus Biotechnology's Total Stockholders Equity for the quarter that ended in Mar. 2011 was $-6.58 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. InNexus Biotechnology's Book Value per Share for the quarter that ended in Mar. 2011 was $-0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. InNexus Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2011 was -1.05.

InNexus Biotechnology Total Stockholders Equity Historical Data

The historical data trend for InNexus Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Total Stockholders Equity Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Total Stockholders Equity

Get a 7-Day Free Trial

1.01

4.77

4.59

-1.70

-4.94

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Total Stockholders Equity	Get a 7-Day Free Trial															-3.99	-4.94	-5.39	-5.89	-6.58

InNexus Biotechnology (GREY:IXSBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

InNexus Biotechnology's Book Value per Share for the quarter that ended in Mar. 2011 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-6.575	-	0.008)	/	163.202
	=	-0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

InNexus Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2011 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.609	+	0.269)	/	-6.575
	=	-1.05

InNexus Biotechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines